Close Menu

carcinoma

Starting with a head and neck cancer patient who showed an impressive response to pembrolizumab, researchers profiled gene fusion neoantigens in several tumor types.

Researchers traced genomic, epigenomic, and expression features in lung carcinoma in situ cases that regressed or progressed to invasive lung squamous cell carcinomas.

At least half a dozen cancer phenotypes showed significant associations with GWAS variant-based polygenic risk scores in a new phenome-wide association study.

Using RNA sequences for thousands of cells, researchers looked at head and neck squamous cell carcinomas and proposed streamlined expression subtypes.

A proof-of-principle study suggests blood and saliva may contain markers for finding and following head and neck squamous cell carcinomas.

TP53 mutations are early drivers of serous tubal intraepithelial carcinomas, but some lesions may be metastases rather than precursors to high-grade serous carcinomas.

Launch Pad for Rising Stars

Premium

Rick Wilson, a bushwhacker involved in the sequencing for the Human Genome Project, is mentoring a new generation of trailblazers in 21st century genomics.

Funding Update for Mar 10, 2009

Premium

NIH Array-Related Grants Awarded Dec. 23, 2008 — March 10, 2009

Imperial College London and its spinout DNA Electronics have created a prototype for the so-called SNP Dr., which is being developed under a £1.2 million project that also includes Pfizer.

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.